Paper21079428
The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study.
Durovni B and 11 others. AIDS, 2010. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study. Papers, record 21079428. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21079428
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antitubercular Agents | Major topic |
| Delivery of Health Care, Integrated | Major topic |
| HIV Infections | Major topic |
| HIV-1 | Major topic |
| Isoniazid | Major topic |
| Tuberculosis | Major topic |
| Brazil | |
| Female | |
| Humans | |
| Incidence | |
| Male | |
| Viral Load |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K01 AI066994 | NIAID NIH HHS | United States | K01AI066994 | PubMed and NIH | NIH RePORTER |
| K24 AI001637 | NIAID NIH HHS | United States | K24AI001637 | PubMed and NIH | NIH RePORTER |
| AI066994 | NIAID NIH HHS | United States | K01AI066994 | PubMed and NIH | NIH RePORTER |
| AI001637 | NIAID NIH HHS | United States | K24AI001637 | PubMed and NIH | NIH RePORTER |
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT03302299 | Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT) | Background | ClinicalTrials.gov | |
| NCT03537872 | PROvide MIner-friendly SErvices for Integrated TB/HIV Care in Lesotho Study | Background | ClinicalTrials.gov |
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17589190 | The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. | AIDS | 2007 | https://conductscience.org/library/papers/17589190 | PubMed |
| 2 | 9233868 | A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS. | N Engl J Med | 1997 | https://conductscience.org/library/papers/9233868 | PubMed |
| 3 | 11092714 | HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group. | Int J Tuberc Lung Dis | 2000 | https://conductscience.org/library/papers/11092714 | PubMed |
| 4 | 18544202 | Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro, Brazil. | Int J Tuberc Lung Dis | 2008 | https://conductscience.org/library/papers/18544202 | PubMed |
| 5 | 9519950 | Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. | Lancet | 1998 | https://conductscience.org/library/papers/9519950 | PubMed |
| 6 | 20091503 | Treatment of latent tuberculosis infection in HIV infected persons. | Cochrane Database Syst Rev | 2010 | https://conductscience.org/library/papers/20091503 | PubMed |
| 7 | 9295239 | A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. | N Engl J Med | 1997 | https://conductscience.org/library/papers/9295239 | PubMed |
| 8 | 9875583 | Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. | AIDS | 1998 | https://conductscience.org/library/papers/9875583 | PubMed |
| 9 | 11684932 | Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil. | AIDS | 2001 | https://conductscience.org/library/papers/11684932 | PubMed |
| 10 | 10997404 | Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. | AIDS | 2000 | https://conductscience.org/library/papers/10997404 | PubMed |
| 11 | 12742798 | The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. | Arch Intern Med | 2003 | https://conductscience.org/library/papers/12742798 | PubMed |
| 12 | 18781195 | AIDS-related tuberculosis in Rio de Janeiro, Brazil. | PLoS One | 2008 | https://conductscience.org/library/papers/18781195 | PubMed |
| 13 | 12086758 | Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. | Lancet | 2002 | https://conductscience.org/library/papers/12086758 | PubMed |
| 14 | 17456522 | Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention. | Clin Trials | 2007 | https://conductscience.org/library/papers/17456522 | PubMed |
| 15 | 11797184 | Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy. | Clin Infect Dis | 2002 | https://conductscience.org/library/papers/11797184 | PubMed |
| 16 | 8101302 | Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. | Lancet | 1993 | https://conductscience.org/library/papers/8101302 | PubMed |
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41666121 | Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial. | PLoS Med | 2026 | https://conductscience.org/library/papers/41666121 | PubMed |
| 39453876 | Sex differences in tuberculosis infection and disease among people with HIV. | AIDS | 2025 | https://conductscience.org/library/papers/39453876 | PubMed |
| 38356778 | A validated liquid chromatography-tandem mass spectrometry assay for the analysis of isoniazid and its metabolite acetyl-isoniazid in urine. | J Mass Spectrom Adv Clin Lab | 2024 | https://conductscience.org/library/papers/38356778 | PubMed |
| 36229905 | Knowledge and Attitudes of Indonesian General Practitioners Towards the Isoniazid Preventive Therapy Program in Indonesia. | J Prev Med Public Health | 2022 | https://conductscience.org/library/papers/36229905 | PubMed |
| 35927793 | Drop-offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015-2019. | J Int AIDS Soc | 2022 | https://conductscience.org/library/papers/35927793 | PubMed |
| 35899273 | Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden Settings. | Open Forum Infect Dis | 2022 | https://conductscience.org/library/papers/35899273 | PubMed |
| 35696431 | Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness. | PLoS Med | 2022 | https://conductscience.org/library/papers/35696431 | PubMed |
| 35231047 | Mixed methods systematic review and metasummary about barriers and facilitators for the implementation of cotrimoxazole and isoniazid-Preventive therapies for people living with HIV. | PLoS One | 2022 | https://conductscience.org/library/papers/35231047 | PubMed |
| 33995803 | Facility and patient barriers in the implementation of isoniazid preventive therapy for people living with HIV attending Care and Treatment Centers, Songea Municipality, Tanzania. | Pan Afr Med J | 2021 | https://conductscience.org/library/papers/33995803 | PubMed |
| 33264300 | Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data. | PLoS One | 2020 | https://conductscience.org/library/papers/33264300 | PubMed |
| 32773999 | Implementation of Isoniazid Preventive Therapy among People Living with HIV in Northwestern Nigeria: Completion Rate and Predictive Factors. | J Glob Infect Dis | 2020 | https://conductscience.org/library/papers/32773999 | PubMed |
| 32664847 | Factors affecting uptake and completion of isoniazid preventive therapy among HIV-infected children at a national referral hospital, Kenya: a mixed quantitative and qualitative study. | BMC Infect Dis | 2020 | https://conductscience.org/library/papers/32664847 | PubMed |
| 32460788 | A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda. | AIDS Res Ther | 2020 | https://conductscience.org/library/papers/32460788 | PubMed |
| 32276618 | Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study. | BMC Infect Dis | 2020 | https://conductscience.org/library/papers/32276618 | PubMed |
| 32180867 | Improving coverage and completion rate of isoniazid preventive therapy among eligible HIV patients using quality improvement approaches: a case study of State Hospital, Ijebu Ode, Ogun State, Nigeria. | Pan Afr Med J | 2019 | https://conductscience.org/library/papers/32180867 | PubMed |
| 32049259 | Access and adherence to isoniazid preventive therapy and occurrence of active TB in a cohort of people living with HIV: a retrospective cohort study in Sao Paulo, Brazil. | Rev Inst Med Trop Sao Paulo | 2020 | https://conductscience.org/library/papers/32049259 | PubMed |
| 31664978 | Inequality in uptake of isoniazid prevention therapy and Mantoux test among pregnant women with HIV in the Eastern Cape, South Africa. | BMC Public Health | 2019 | https://conductscience.org/library/papers/31664978 | PubMed |
| 31634189 | CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIV. | AIDS | 2020 | https://conductscience.org/library/papers/31634189 | PubMed |
| 30758779 | Tolerability of Isoniazid Preventive Therapy in an HIV-Infected Cohort of Paediatric and Adolescent Patients on Antiretroviral Therapy from a Resource-Limited Setting: A Retrospective Cohort Study. | Drugs Real World Outcomes | 2019 | https://conductscience.org/library/papers/30758779 | PubMed |
| 30174886 | Effects of preventive therapy for latent tuberculosis infection and factors associated with treatment abandonment: a cross-sectional study. | J Thorac Dis | 2018 | https://conductscience.org/library/papers/30174886 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| HPD | 3242 | PubTator's text mining | https://conductscience.org/library/genes/3242 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21079428
GET https://conductscience.org/api/papers/v1/21079428/cited_by?page=2